Brockmann Bobbi Jo bought ICCC

January 27, 2026 · Form 4 insider transaction

Brockmann Bobbi Jo bought 100,000 shares of ImmuCell Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
Role
SecurityStock Options (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 27, 2026
Filing dateJanuary 29, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Option grant made to Ms. Brockmann in connection with her employment as Vice President of Sales and Marketing. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 33,333 shares becoming exercisable on each of January 27, 2027 and January 27, 2028 and 33,334 shares becoming exercisable on January 27, 2029.

View the original Form 4 on SEC EDGAR
Brockmann Bobbi Jo bought ICCC: January 27, 2026 | Insider Trading Screener